Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Stemgent
3122
Stemgent
Technology
Biotechnology
Stemgent is a leading supplier providing mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services.
Suggest edits
Founded
2008
Raised
$16.7M
Follow us
Companies in the same industry
Thar Pharmaceuticals
Cancer Treatment Services International
ViewPoint Therapeutics
EnBiotix, Inc.
IRX Therapeutics, Inc.
Nucleix Ltd.
ALSP, Inc.
Entegrion
AiVita Biomedical
EmeraMed Limited
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$2,700,000
Debt financing - 2009
Morgenthaler Ventures
HealthCare Ventures
$14,000,000
Venture capital (Series B) - 2009
Morgenthaler Ventures
Frazier Healthcare Partners
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Stemgent makes some noise.
